Champignon Brands Acquires Ketamine Clinic Operator AltMed Capital

April 10, 2020 1:28 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Champignon Brands Acquires Ketamine Clinic Operator AltMed Capital

Psychedelics research company Champignon Brands (CSE:SHRM) (OTC:SHRMF) announced Friday it is acquiring AltMed Capital Corp.

Run by Dr. Roger McIntyre, AltMed has been operating a ketamine clinic, the Health Canada-approved Canadian Rapid Treatment Centre of Excellence (CRTCE), for more than 18 months now.

Dr. McIntyre is well known in his field, having published more than 600 articles. AltMed’s director, Pat McCutcheon, is the co-founder and CEO of MediPharm Labs (TSX:LABS) (OTC:MEDIF).

Chatting with Benzinga, Dr. McIntyre said, "Our new corporation is the largest and most influential company in the world that integrates both research and development of ketamine and psychedelic medicines along with excellence in the multidisciplinary care of persons with mood and related disorders (e.g. PTSD, pain substance abuse)."




For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Cannabis M&A News Markets

Related Articles

The Flowr Corp. To Export Up To 500KG Of Medical Cannabis To Israel

The Flowr Corporation (OTCQX: FLWPF) will export up to 500 kilos of premium dry cannabis flower in bulk into Israel. The move follows the company's recent announcement that it had raised $15.9 million by selling units. read more

The Week In Cannabis: New York, New Mexico, YouTube, KushCo, Greenlane And More

A shortened week came with no shortage of news. In New York, Gov. Andrew Cuomo signed recreational marijuana into law on Wednesday, making the Empire State the 15th in the U.S. to legalize cannabis. read more

Cannabis Stock Gainers And Losers From February 5, 2021

GAINERS: MedMen Enterprises Inc - Class B (Sub Voting) (OTCQX: MMNFF) shares closed up 57.35% at $0.43 read more

South African Spirits Company Distell Backs Cannabis Brand Rethink

South African wine and spirits company Distell is now in the cannabis industry. The producer of Bunnahabhain and Deanston Scotch whiskies teamed up with venture capital firm Invenfin to invest in cannabis wellness brand Rethink, The Spirits Business reports. read more